Results 261 to 270 of about 532,008 (348)
Speech Differences between Multiple System Atrophy and Parkinson's Disease
Abstract Background Delineation of Parkinson's disease (PD) from multiple system atrophy (MSA) can be challenging in early disease stages. Speech characteristics have been studied as digital biomarkers in PD and ataxias. Currently, data on speech in MSA is limited.
Tom Hähnel+9 more
wiley +1 more source
New Technological Approaches in Occupational Therapy for Pediatric Cerebral Palsy: A Systematic Review. [PDF]
Martínez-Rodríguez L+4 more
europepmc +1 more source
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister+11 more
wiley +1 more source
Retracted: Prevention of Physical Risk and Rehabilitation of Muscle Injury in Sanda Competition
Occupational Therapy International
doaj +1 more source
Examining the Effectiveness of a Group Occupational Therapy Program During the Early Stage of Psychiatric Hospitalization in Japan: A Randomized Controlled Trial. [PDF]
Sasaki T, Tanimura A.
europepmc +1 more source
Myoclonic Dystonia: A Common Phenomenology in the Pleomorphic Movements of Angelman Syndrome
Abstract Background Angelman syndrome (AS) is a neurodevelopmental disorder characterized by developmental delay, intellectual disability, a sociable demeanor, and abnormal movements. People with AS often exhibit multiple types of abnormal movements, including nonepileptic myoclonus, tremor, and dystonia, which hamper attempts to identify phenomenology
Robert P. Carson+8 more
wiley +1 more source
Occupational therapy students' and educators' perspectives and understanding of the role of occupational therapy within social prescribing: A qualitative interview study. [PDF]
Elliott S, Haighton C.
europepmc +1 more source
Abstract Background Deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) can effectively treat motor symptoms of Parkinson's disease (PD). However, optimal patient selection remains challenging due to the inadequacy of outcome predictors.
John R. Younce+3 more
wiley +1 more source